Howard M, O'Garra A
DNAX Research Institute, Palo Alto, CA 94304-1104.
Immunol Today. 1992 Jun;13(6):198-200. doi: 10.1016/0167-5699(92)90153-X.
An enormous amount of information on interleukin 10 (IL-10) has been gathered since its original description as cytokine synthesis inhibition factor (CSIF) several years ago. In this short article, Maureen Howard and Anne O'Garra summarize what is currently known of the biological properties of IL-10 and speculate on its clinical potential.
自从白细胞介素10(IL-10)几年前最初被描述为细胞因子合成抑制因子(CSIF)以来,已经收集了大量关于它的信息。在这篇短文中,莫林·霍华德和安妮·奥加拉总结了目前已知的IL-10的生物学特性,并推测了其临床潜力。